A study to observe the side effects and patient recovery following administration of a Clot breaking drug called Alteplase in a stroke patient in a tertiary care hospital.
Not Applicable
- Conditions
- Health Condition 1: null- good
- Registration Number
- CTRI/2018/04/013094
- Lead Sponsor
- Department of Pharmacolog
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
patients aged 18 to 80 years diagnosed with acute ischemic stroke and who has been administered Alteplase would be included.
Exclusion Criteria
Those who are contraindicated for thrombolysis.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Assessment of safety profile of Alteplase administration in acute ischemic stroke <br/ ><br> <br/ ><br>2.Assessment of major neurological improvement using National Institute of Health Stroke Scale ( NIHSS) at 2 hour and 24- 36 hour.Timepoint: NIHSS scoring at 2 hour and 24- 36 hour.
- Secondary Outcome Measures
Name Time Method assessment of short term functional outcome using Modified Ranking ScaleTimepoint: day 7 or earlier( if discharged earlier) <br/ ><br> <br/ ><br>Day 90.